A detailed history of Harbour Investment Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Harbour Investment Management LLC holds 34,950 shares of PFE stock, worth $959,727. This represents 0.45% of its overall portfolio holdings.

Number of Shares
34,950
Previous 34,290 1.92%
Holding current value
$959,727
Previous $959,000 5.42%
% of portfolio
0.45%
Previous 0.45%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$27.7 - $31.39 $18,282 - $20,717
660 Added 1.92%
34,950 $1.01 Million
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $114,048 - $133,644
4,515 Added 15.16%
34,290 $959,000
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $74,433 - $85,473
2,875 Added 10.69%
29,775 $826,000
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $169,061 - $219,591
-6,470 Reduced 19.39%
26,900 $774,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $159,615 - $186,574
4,974 Added 17.52%
33,370 $1.11 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $1.03 Million - $1.19 Million
28,396 New
28,396 $1.04 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $247,275 - $317,646
-6,300 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $210,987 - $237,951
6,300 New
6,300 $228,000
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $187,541 - $213,817
-4,875 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$34.47 - $41.81 $168,041 - $203,823
4,875 New
4,875 $215,000
Q2 2018

Jul 31, 2018

SELL
$32.98 - $35.16 $206,949 - $220,628
-6,275 Closed
0 $0
Q1 2018

Apr 30, 2018

SELL
$31.91 - $37.02 $1,595 - $1,851
-50 Reduced 0.79%
6,275 $223,000
Q4 2017

Feb 02, 2018

SELL
$33.26 - $35.29 $16,630 - $17,645
-500 Reduced 7.33%
6,325 $229,000
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $211,575 - $233,073
6,825
6,825 $244,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Harbour Investment Management LLC Portfolio

Follow Harbour Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investment Management LLC with notifications on news.